BioSpace News Archive

Drug Development

Pfizer’s NASH Treatment Lands FDA Fast Track Designation

Pfizer announced the FDA has granted its combinatorial therapeutic ervogastat/clesacostat Fast Track Designation that is intended for the treatment of NASH with liver fibrosis.

May 26, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Once Hopeful Critical COVID-19 Treatment Reaches Futility

ZYESAMI, (aviptadil), being assessed by NRx Pharmaceuticals, failed a review conducted by the Data Safety and Monitoring Board (DSMB), with the board recommending that arm of the trial cease.

May 26, 2022
·
2 min read
·
Hannah Chudleigh
Drug Development

Researchers Discover Potential New Treatment for ALS

Two researchers affiliated with Northwestern University have discovered a new drug that may outperform existing treatments for amyotrophic lateral sclerosis (ALS).

May 26, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Acer Therapeutics Readies for FDA Ruling on UCDs Drug

On June 5, the FDA is expected to decide the fate of Acer Therapeutics’ experimental treatment for Urea Cycle Disorders (UCDs), ACER-001. CEO Chris Schelling spoke with BioSpace.

May 26, 2022
·
4 min read
·
Alex Keown
Business

BioSpace Movers & Shakers: New Appointments for Maraganore, Afeyan

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

May 26, 2022
·
7 min read
·
Alex Keown
Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform

Full-Life Technologies (“Full-Life”) today announced it completed a $37 million (USD) Series A financing round to advance the development of its radiopharmaceutical oncology product pipeline and its radiotechnology production platform.

May 26, 2022
·
2 min read
Pharm Country

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI® (aviptadil) in Critical COVID-19

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced results of a review conducted by the Data Safety and Monitoring Board on May 25, 2022.

May 26, 2022
·
4 min read
Cellulite Treatment Market Is Set to Expand at A CAGR Of 7.8% To Reach US$ 5.2 Billion By the Year 2028 - Comprehensive Research Report By FMI

DUBAI, United Arab Emirates, A new research report by Future Market Insights revolves around examining the current scenario of global cellulite treatment market as well as forecast for its upcoming years.

May 26, 2022
·
4 min read
Cancer Profiling Market Insights by Size, Status and Forecast 2030

Albany NY, United States: Cancer profiling is an alternative to all traditional approaches to cancer treatment.

May 26, 2022
·
8 min read
Brachytherapy Treatment Planning Systems Market Insights: Size | Shares | Trends | Growth – Forecast [2020-2030]

The brachytherapy treatment planning systems market has been predicted to rise at a noticeable speed in the forthcoming years.

May 26, 2022
·
6 min read